Back to search

National and Kapodistrian University of Athens

Μελέτη του πάχους του ενδοθηλιακού γλυκοκάλυκα και δεικτών αγγειακής λειτουργίας σε ασθενείς με σακχαρώδη διαβήτη τύπου 2 και λευκωματινουρία μετά απο χορήγηση ντουλαγλουτίδης και δαπαγλιφοζίνης έναντι DPP-4 αναστολέων

Abstract

dc:description

BACKGROUND: The association between diabetes mellitus and diabetic nephropathy with vascular and endothelial properties is well established. In this study, we compared the effect of combined treatment with dulaglutide and dapagliflozin versus DPP-4 inhibitors on endothelial glycocalyx, arterial stiffness, myocardial function and albuminuria in patients with type 2 diabetes mellitus and albuminuria. METHODS: A total of 60 patients with type 2 diabetes mellitus and albuminuria were randomized to combined dulaglutide and dapagliflozin treatment (n=30) or DPP-4 inhibitors (DPP-4is, n=30). We measured at baseline and 4 and 12 months posttreatment: (a) perfused boundary region of the sublingual arterial micro vessels (marker of endothelial glycocalyx thickness), (b) pulse wave velocity (PWV) and central systolic blood pressure(cSBP), (c) global left ventricular longitudinal strain (GLS) (d) urine albumin-to creatinine ratio (UACR).RESULTS: Twelve months posttreatment, the combination of dulaglutide and dapagliflozin showed a greater improvement in all indices compared to DPP-4is, despite a similar reduction in glycosylated hemoglobin. Specifically, dual therapy showed greater improvements vs DPP-4is in PBR (2,10±0,31 to 1,93±0,23 μm vs 2,11±0,31 to 2,08±0,28 μm, p(326±61 to 142±47 mg/g vs 345±48 to 306±60 mg/g, p(11,77±2,37 to 10,7±2,29 m/s vs 10,64±2,44 to 10,54±2,84 m/s, p only dual therapy showed improvement in cSBP (130,21±17,23 to 123,36±18,42 mmHg). Regarding GLS, both treatments were effective, but dual therapy showed a significantly higher percentage improvement compared to DPP-4is (18,19% vs 6,01%, respectively). CONCLUSIONS: Twelve-month treatment with dulaglutide and dapagliflozin showed a greater improvement in vascular markers an albuminuria than DPP-4is in patients with type 2 diabetes mellitus and albuminuria. Early initiation of combined therapy as add-on to metformin should be considered in these patients.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Korakas, Emmanouil
  • Κόρακας, Εμμανουήλ

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/55914

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Korakas, Emmanouil; Κόρακας, Εμμανουήλ. Μελέτη του πάχους του ενδοθηλιακού γλυκοκάλυκα και δεικτών αγγειακής λειτουργίας σε ασθενείς με σακχαρώδη διαβήτη τύπου 2 και λευκωματινουρία μετά απο χορήγηση ντουλαγλουτίδης και δαπαγλιφοζίνης έναντι DPP-4 αναστολέων. National and Kapodistrian University of Athens, 2024. http://hdl.handle.net/10442/hedi/55914